Austin Health

Title
Personalized Chemosensitivity Assays for Mesothelioma: Are They Worth the Effort?
Publication Date
2018-04-01
Author(s)
John, Thomas
Chia, Puey Ling
Type of document
Journal Article
DOI
10.1158/1078-0432.CCR-17-3493
Abstract
Cell lines formed from an individual's tumor can be used to predict response to specific therapies and determine genomic predictors. For mesothelioma, where chemotherapy remains the backbone of current therapeutic paradigms, such assays could be used to treat patients with the most effective agents specific to their "chemical profile." Clin Cancer Res; 24(7); 1513-5. ©2018 AACRSee related article by Schunselaar et al., p. 1761.
Link
link
Citation
Clinical Cancer Research 2018; 24(7): 1513-1515
Jornal Title
Clinical Cancer Research
ISSN
1078-0432

Files:

NameSizeformatDescriptionLink